Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Free NLSPW Stock Alerts

NLS Pharmaceutics (NLSPW) SEC Filings & 10K Form

NLS Pharmaceutics logo
$0.02 +0.00 (+3.25%)
As of 07/18/2025 02:23 PM Eastern
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/17/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
6:31 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:57 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13D
06/23/2025
4:29 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
06/16/2025
6:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
6:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
06/10/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
7:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
05/01/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
12/30/2024
5:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSPW) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored